Albumedix

Albumedix is a science-driven company and a recognized leader in premier albumin solutions. Founded in 1984 in the UK, Albumedix's mission is to achieve excellence and support its life science partners in delivering hundreds of millions of safe doses of clinical and marketed therapies worldwide. Albumedix's solutions include the world's only USP-NF compliant (Recombumin®) and (Veltis®). By continuously striving for more and collaboratively challenging the status quo, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals for the benefit of people around the globe. Albumedix primarily engages in the research and development of recombinant albumin products and technologies, which can be used as animal-free additives in cell culture media and to stabilize vaccines and viral therapies.